Search Results 541-550 of 7743 for SC

  1. CA 125 test: A screening test for ovarian cancer? - Mayo Clinic

    Answer From Tatnai Burnett, M.D.. The cancer antigen 125 (CA 125) blood test generally isn't recommended if you have an average risk of ovarian cancer.

  2. Roberto Cattaneo, Ph.D. - Mayo Clinic Faculty Profiles

    Sc.) - Biology: Cloning of immunoglobulin genes in cosmid vectors University of Geneva. src="/-/media/kcms/gbs/research/images/. Clinical Studies. Learn about ...

  3. Publications - Doug W. Challener, M.D., M.S. - Mayo Clinic

    Challener DW, Dowdy SC, O'Horo JC. Analytics and Prediction Modeling During the COVID-19 Pandemic. Mayo Clin Proc. 2020 Sep; 95 (9S):S8-S10 Epub 2020 June ...

  4. A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

    Treatment with i.v. or s.c. prostanoids within 4 weeks before randomization, unless given for vasoreactivity testing. Hemoglobin or hematocrit <75% of the ...

  5. A Study to Evaluate the Effectiveness and Safety of RalinEpag for Improving Treatment Outcomes in PAH Patients - Mayo Clinic

    Hemoglobin concentration <9 g/dL at Screening. 12. Subjects treated with an IV or SC prostacyclin pathway agent (eg, epoprostenol, treprostinil, or iloprost) ...

  6. A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis - Mayo Clinic

    Medically (either independently or with caregiver assistance) able to comply with study procedures, including subcutaneous (SC) injections of study medication ...

  7. Mild Cognitive Impairment Clinical Trials - Mayo Clinic Research

    Eligible participants will be randomized 1:1 to receive either subcutaneous (SC) injection of gantenerumab or placebo. The primary efficacy assessment will ...

  8. A Study to Evaluate the Effectiveness and Safety of Ralinepag To Improve Treatment Outcomes in Peripheral Arterial Hypertension (PAH) Patients - Mayo Clinic

    Subjects treated with an IV or SC prostacyclin pathway agent (e.g., epoprostenol, treprostinil, or iloprost) at any time prior to Baseline (use in vasoreactive ...

  9. Arteriosclerosis / atherosclerosis - Diagnosis and treatment - Mayo Clinic

    To diagnose atherosclerosis, your healthcare professional examines you and listens to your heart. You usually are asked questions about your symptoms and ...

  10. Publications - Christian Hanna, M.D., M.S. - Mayo Clinic

    Rozen-Zvi B, Hayashida T, Hubchak SC, Hanna C, Platanias LC, Schnaper HW. TGF-beta/Smad3 activates mammalian target of rapamycin complex-1 to promote ...